Interleukin-6 trans-signalling and risk of future cardiovascular events: a new avenue for atheroprotection?
Open Access
- 14 September 2018
- journal article
- editorial
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 115 (1) , 8-9
Abstract
This editorial refers to ‘Interleukin 6 trans-signalling and risk of future cardiovascular events’ by L. Ziegler et al., pp. 213–221.Keywords
Funding Information
- European Research Council, Advanced (294609)
- Proof of Concept Grant (713734)
- Italian Ministry of Health (PE-2013-02356818)
- CARIPLO foundation (2015-0573)
- Italian Ministry of Education, University and Research (2015583WMX)
This publication has 14 references indexed in Scilit:
- From C-Reactive Protein to Interleukin-6 to Interleukin-1Circulation Research, 2016
- Interleukin-6: Biology, signaling and strategies of blockadeCytokine & Growth Factor Reviews, 2015
- Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarctionAtherosclerosis, 2015
- Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysisEuropean Heart Journal, 2013
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory DiseasesPLOS Genetics, 2013
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysisThe Lancet, 2012
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studiesThe Lancet, 2012
- Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994